Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. 1991

M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
Department of Genetics, Emory University School of Medicine, Atlanta, GA 30322.

OBJECTIVE --Oxidative phosphorylation (OXPHOS) deficiency due to hypoxemia or other causes was hypothesized to increase oxygen radical generation, damage mitochondrial DNA (mtDNA), and reduce adenosine triphosphate synthesis, resulting in compensatory OXPHOS gene induction. Therefore, we investigated the levels of mtDNA damage and OXPHOS transcripts in normal and ischemic hearts, and then in other forms of heart disease. METHODS --DNA was extracted from the heart and the levels of the common 4977 base pair mtDNA deletion were quantitated as an index for mtDNA damage. Total RNA was extracted from hearts and analyzed for OXPHOS transcript levels. RESULTS --In control hearts, the 4977 base pair mtDNA deletion appeared at age 40 years and reached a maximum deletion of 0.0035%. Much higher levels were found in ischemic hearts (0.02% to 0.85%), as well as in three of 10 cases with other types of heart disease (0.017% to 0.16%). The OXPHOS transcripts were increased in all diseased hearts. CONCLUSIONS --Ischemic hearts have increased mtDNA damage and OXPHOS gene expression, suggesting that mtDNA damage is associated with OXPHOS deficiency. Oxidative phosphorylation defects may also play a role in some other forms of cardiac disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008929 Mitochondria, Heart The mitochondria of the myocardium. Heart Mitochondria,Myocardial Mitochondria,Mitochondrion, Heart,Heart Mitochondrion,Mitochondria, Myocardial
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
October 2012, Free radical biology & medicine,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
August 2020, DNA and cell biology,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
September 2013, Neurobiology of aging,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
October 2014, Lupus,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
January 2012, Biochimica et biophysica acta,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
January 2019, The Journal of nutritional biochemistry,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
January 2021, Frontiers in cardiovascular medicine,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
July 2004, Mitochondrion,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
February 2021, DNA and cell biology,
M Corral-Debrinski, and G Stepien, and J M Shoffner, and M T Lott, and K Kanter, and D C Wallace
March 2023, International journal of molecular sciences,
Copied contents to your clipboard!